GVK-backed Oval Fertility launched in Hyderabad, eyes share in India's growing IVF market
Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow Tucker- Biocon shifts focus to margins, capacity utilisation after expansion phase
- Kiran Mazumdar-Shaw picks niece Claire as successor at Biocon
- FeaturedUTI Nifty 50 Index Direct-G-4.14-9.65-6.748.68
- -4.132.105.1821.40
- 1.23-3.52-2.0114.62
- Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report
- Biocon rolls out two biosimilars in US market
- Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj Chinthalapelly
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence- SC grills Sebi over lingering probe against Sandesara brothers despite Rs 5,100 cr settlement
- Zydus launches biosimilar for ophthalmic care
- CM Revanth Reddy pitches Telangana as biopharma investment destination
- Adven Biotech says it's India's first homeopathic brand to get NABL certification
- Budget 2026: Govt to upgrade allied health institutions, train 1 lakh professionals
- Union Budget 2026: Govt to overhaul drug regulator CDSCO, announces Rs 10,000 crore ‘Biopharma Shakti’ push
- Boehringer Ingelheim, Viyash Scientific enter pet healthcare pact in India
- Zydus launches biosimilar for treatment of multiple cancers
- Biocon Biologics to introduce three new biosimilars for cancer treatment
- Biocon Biologics gets global rights for biosimilar Adalimumab
- Centre weighs new law to regulate medical research
- Zydus Lifesciences introduces biosimilar to protect bone health in cancer patients
Top Mutual Funds
3 M(%)
6 M(%)
1 YR(%)
3 YRS(%)